Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akoya Biosciences Inc 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01752 USA

www.akoyabio.com Employees: 205 P: 855-896-8401

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM) platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. Akoya Biosciences Inc. is based in MARLBOROUGH, Mass.

Key Statistics

Overview:

Market Capitalization, $K 64,441
Enterprise Value, $K 128,841
Shares Outstanding, K 49,954
Annual Sales, $ 81,670 K
Annual Net Income, $ -55,370 K
Last Quarter Sales, $ 16,640 K
Last Quarter Net Income, $ -15,650 K
EBIT, $ -38,550 K
EBITDA, $ -30,900 K
60-Month Beta 1.36
% of Insider Shareholders 7.30%
% of Institutional Shareholders 79.42%
Float, K 46,307
% Float 92.70%
Short Volume Ratio 0.23

Growth:

1-Year Return -38.28%
3-Year Return -90.34%
5-Year Return 0.00%
5-Year Revenue Growth 93.35%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 05/12/25
Next Earnings Date 08/04/25
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr -88.24%
EPS Growth vs. Prev Year 8.57%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AKYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -487.85%
Return-on-Assets % -35.86%
Profit Margin % -67.80%
Debt/Equity -12.99
Price/Sales 0.83
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.12
Interest Coverage -4.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar